EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

Breitkreutz, 2007, Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium, J. Cancer Res. Clin. Oncol., 133, 793, 10.1007/s00432-007-0280-3 Brown, 2008, NF-kappaB in carcinoma therapy and prevention, Expert Opin. Ther. Targets, 12, 1109, 10.1517/14728222.12.9.1109 Chen, 2007, Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin ligase, J. Biol. Chem., 282, 33776, 10.1074/jbc.M703320200 Cheung, 2006, Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma, Mod. Pathol., 19, 1034, 10.1038/modpathol.3800635 Choi, 2007, On/off-regulation of phospholipase C-gamma 1-mediated signal transduction, Adv. Enzyme Regul., 47, 104, 10.1016/j.advenzreg.2006.12.010 Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, 452, 230, 10.1038/nature06734 Clower, 2010, The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism, Proc. Natl. Acad. Sci. USA, 107, 1894, 10.1073/pnas.0914845107 Cordier, 2009, The zinc finger of NEMO is a functional ubiquitin-binding domain, J. Biol. Chem., 284, 2902, 10.1074/jbc.M806655200 David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697 Ea, 2006, Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO, Mol. Cell, 22, 245, 10.1016/j.molcel.2006.03.026 Furnari, 2007, Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes Dev., 21, 2683, 10.1101/gad.1596707 Ghosh, 2008, New regulators of NF-kappaB in inflammation, Nat. Rev. Immunol., 8, 837, 10.1038/nri2423 Hayden, 2004, Signaling to NF-kappaB, Genes Dev., 18, 2195, 10.1101/gad.1228704 Hoffmann, 2006, Transcriptional regulation via the NF-kappaB signaling module, Oncogene, 25, 6706, 10.1038/sj.onc.1209933 Hornia, 1999, Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor, Mol. Cell. Biol., 19, 7672, 10.1128/MCB.19.11.7672 Ji, 2009, EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin, Mol. Cell, 36, 547, 10.1016/j.molcel.2009.09.034 Karin, 2006, Nuclear factor-kappaB in cancer development and progression, Nature, 441, 431, 10.1038/nature04870 Kuan, 2001, EGF mutant receptor vIII as a molecular target in cancer therapy, Endocr. Relat. Cancer, 8, 83, 10.1677/erc.0.0080083 Lu, 2012, Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis, Chin. J. Cancer, 31, 5 Lu, 1998, Activation of protein kinase C triggers its ubiquitination and degradation, Mol. Cell. Biol., 18, 839, 10.1128/MCB.18.2.839 Luo, 2011, Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1, Cell, 145, 732, 10.1016/j.cell.2011.03.054 Mazurek, 2005, Pyruvate kinase type M2 and its role in tumor growth and spreading, Semin. Cancer Biol., 15, 300, 10.1016/j.semcancer.2005.04.009 Nakamura, 2006, Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex, Biochem. Biophys. Res. Commun., 351, 340, 10.1016/j.bbrc.2006.09.163 Nogami, 2003, Requirement of autophosphorylated tyrosine 992 of EGF receptor and its docking protein phospholipase C gamma 1 for membrane ruffle formation, FEBS Lett., 536, 71, 10.1016/S0014-5793(03)00013-9 Rahighi, 2009, Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation, Cell, 136, 1098, 10.1016/j.cell.2009.03.007 Rius, 2008, NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha, Nature, 453, 807, 10.1038/nature06905 Schroeder, 1969, An examination of conditions for the cleavage of polypeptide chains with cyanogen bromide: application to catalase, Arch. Biochem. Biophys., 130, 551, 10.1016/0003-9861(69)90069-1 Skaug, 2009, The role of ubiquitin in NF-kappaB regulatory pathways, Annu. Rev. Biochem., 78, 769, 10.1146/annurev.biochem.78.070907.102750 Sun, 2011, Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth, Proc. Natl. Acad. Sci. USA, 108, 4129, 10.1073/pnas.1014769108 Tokunaga, 2009, Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation, Nat. Cell Biol., 11, 123, 10.1038/ncb1821 Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 Voldborg, 1997, Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials, Ann. Oncol., 8, 1197, 10.1023/A:1008209720526 Wang, 2001, TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature, 412, 346, 10.1038/35085597 Wu, 2006, Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected], Nat. Cell Biol., 8, 398, 10.1038/ncb1384 Wykosky, 2011, Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations, Chin. J. Cancer, 30, 5, 10.5732/cjc.010.10542 Yang, 2012, PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis, Cell, 150, 685, 10.1016/j.cell.2012.07.018 Yang, 2011, Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation, Nature, 480, 118, 10.1038/nature10598